Actinium Pharmaceuticals Inc (ATNM)
Healthcare
Biotechnology
0.84 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Actinium Pharmaceuticals Inc (ATNM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.4% of the shares are freely tradable; institutional investors hold 20.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
20.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
31Mio.
No ownership data is available for this stock yet.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.